Phase I trial of three-weekly Docetaxel, Carboplatin and oral lenalidomide (Revlimid®) in patients with advanced solid tumors
Year: 2006
Type: article
Study design: Clinical Trial
Source: Investigational New Drugs
Authors: S. Kalmadi, M. Davis, A. Dowlati, S. O’Keefe, M. Cline-Burkhardt, R. J. Pelley, E. Borden, R. Dreicer, R. Bukowski, T. Mekhail
Institution: Cleveland Clinic
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2015403929